[Multiple sclerosis. Treatment: hopes and realities].
Lubetzki
C
C
Fédération de Neurologie et INSERM U-134, Hôpital de la Salpêtrière, Paris.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007167:Immunotherapy / Q000639:trends; D009103:Multiple Sclerosis / Q000628:therapy*; D011379:Prognosis
D000276:Adjuvants, Immunologic; D007166:Immunosuppressive Agents